OCD Trial, Recruiting (NCT05906069)

OCD Trial, Recruiting NCT05906069 Sponsor: Pedro Morgado Condition: OCD

Printed from Voxsanity (voxsanity.com.au) — NCT05906069 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ocd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with OCD (Obsessive-Compulsive Disorder) as your main condition, based on current medical guidelines
Your OCD symptoms are rated as moderate to severe, based on a standard symptom checklist called the YBOCS (confirm with trial site for exact score requirements)
If you are taking any psychiatric medications, your dose has been stable for at least 2 months before joining and would need to stay the same throughout the study
You have access to the internet and a computer or tablet to take part in the online parts of the trial

Who may not be able to join:

You have a medical reason why you cannot have an MRI scan (for example, a metal implant or pacemaker)
You have a history of a neurological condition or a traumatic brain injury
You have received CBT (Cognitive Behavioural Therapy) specifically for OCD within the last 2 years
You are currently receiving any form of psychological therapy or counselling
You are currently experiencing thoughts of suicide
You are currently misusing alcohol or drugs

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pedro Morgado, M.D, Ph.D., Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho

Phone: +351 253 604 931

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05906069

Sponsor: Pedro Morgado

Phase: Not Applicable

Status: Recruiting

Condition: OCD

Trial contact: +351 253 604 931

More information: https://clinicaltrials.gov/study/NCT05906069

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with OCD (Obsessive-Compulsive Disorder) as your main condition, based on current medical guidelines
Your OCD symptoms are rated as moderate to severe, based on a standard symptom checklist called the YBOCS (confirm with trial site for exact score requirements)
If you are taking any psychiatric medications, your dose has been stable for at least 2 months before joining and would need to stay the same throughout the study
You have access to the internet and a computer or tablet to take part in the online parts of the trial

Who may not be able to join:

You have a medical reason why you cannot have an MRI scan (for example, a metal implant or pacemaker)
You have a history of a neurological condition or a traumatic brain injury
You have received CBT (Cognitive Behavioural Therapy) specifically for OCD within the last 2 years
You are currently receiving any form of psychological therapy or counselling
You are currently experiencing thoughts of suicide
You are currently misusing alcohol or drugs

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Pedro Morgado

Registry

ClinicalTrials.gov

Start date

2 May 2023

Est. completion

1 September 2025

Where this trial is recruiting

🇵🇹 Portugal

Primary endpoints

Change in the Yale-Brown Obsessive Compulsive Scale (Y-BOCS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov